Influencing factors |
| HR | 95% CI | P |
Gender | male | 0.892 | 0.531 - 1.499 | 0.67 |
Age | >60 | 1.441 | 0.763 - 2.718 | 0.26 |
Stage | III/IV | 1.490 | 0.878 - 2.529 | 0.14 |
Group | B | 1.501 | 0.850 - 2.651 | 0.16 |
Extranodal involvement | >1 | 1.881 | 1.081 - 3.275 | 0.02* |
IPI score | high | 2.627 | 1.541 - 4.476 | 0.00** |
R therapy | no | 1.492 | 0.888 - 2.508 | 0.13 |
Anemia | yes | 1.572 | 0.939 - 2.629 | 0.08 |
LDH | increase | 1.915 | 1.146 - 3.200 | 0.01** |
β2-MG | increase | 1.678 | 0.883 - 3.186 | 0.11 |
CA125 | increase | 1.389 | 0.759 - 2.540 | 0.29 |
CRP | increase | 2.066 | 1.224 - 3.485 | 0.01** |
ALB | decrease | 2.907 | 1.730 - 4.886 | 0.00** |
D-D | increase | 1.858 | 0.841 - 4.109 | 0.13 |
CAR | increase | 2.210 | 1.317 - 3.708 | 0.00** |